Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells
Yashaswini Kannan(The Francis Crick Institute), Mark S. Wilson(Gene Therapy Laboratory), Isobel Okoye, Steven C. Ley(University College London), Srividya Sriskantharajah(The Francis Crick Institute), Yanda Li(Chinese Academy of Sciences), Victoria S. Pelly(Wellcome Trust), Nikolay P. Nikolov(National Institutes of Health), Andrew S. MacDonald(University of Manchester), Lauren M. Webb(University of Manchester), Stephanie M. Coomes(The Francis Crick Institute), Stephanie Czieso, Eva Gückel(The Francis Crick Institute)
Cited by 15
Related Papers
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k
Pulmonary fibrosis: pathogenesis, etiology and regulation
|Mucosal Immunology|2009|834
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
|PLoS Pathogens|2009|808
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740
Suppression of allergic airway inflammation by helminth-induced regulatory T cells
|The Journal of Experimental Medicine|2005|609